New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
Cipla and Ethris partner for the development of mRNA-based therapies
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
Price was the key driver for the period
The company will donate 5000 nebulizers to primary health care centres in rural India
The agreement is to develop, manufacture and commercialise biosimilars for the global market.
Subscribe To Our Newsletter & Stay Updated
